The expression of SLC12A5 was further found significantly higher in the NE positive tumor tissues than that in the NE negative tissues (P < 0.05) (GSE126078, Fig. 3B) as well as significantly higher in androgen-insensitive prostate cancer cell lines compared to androgen-sensitive prostate cancer cell lines (P < 0.05) (GSE4016, Fig. 3C). This evidence concerns the gene SLC12A5 and prostate carcinoma.